Secretary RFK Jr’s dismissal of the CDC’s Advisory Committee on Immunization Practices (ACIP) has raised concerns among public health experts and Congress members, who argue this move could endanger vaccination integrity and public safety. Calls for reinstating the fired members and criticism of RFK Jr’s anti-vaccine agenda are mounting amid ongoing vaccination challenges.
RFK Jr Moves to Destroy ACIP Read More »
In 2025, North America faces a significant measles outbreak linked to cases in Texas, Canada, and Mexico. Over 2,755 cases are reported in Canada, primarily among unvaccinated individuals, while Mexico has over 4,100 suspected cases and five fatalities, mostly affecting unvaccinated children. Vaccination rates must improve to curb this resurgence.
The North American Measles Outbreak of 2025 Read More »
The FDA has approved Novavax’s Nuvaxovid, a non-mRNA COVID vaccine aimed at adults 65 and high-risk individuals aged 12-64. Although the approval is limited, many people qualify due to underlying conditions. Nuvaxovid offers an effective alternative, with simpler storage and fewer side effects compared to other vaccines.
The Novavax COVID Vaccine Has Been Approved Read More »
As measles cases rise, many seek guidance on protection measures. Maternal immunity lasts about three months for newborns, with early MMR doses recommended in high-risk areas. Adults typically require two doses for lasting immunity. While the vaccine is effective against all strains, breakthrough cases can occur, albeit milder. Vaccination remains crucial to prevent serious disease.
Measles Protection Questions and Answers Read More »
You must be logged in to post a comment.